Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HCP2001
- Development stage
- Unknown
- Lead developer
- Hanmi Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
HCP2001 is a small molecule drug developed by Hanmi Pharmaceutical. It has been evaluated in a Phase 1 clinical trial as a fixed-dose combination product, with the study designed to compare its pharmacokinetic characteristics and safety profile against the co-administration of each component separately in healthy volunteers. The specific active ingredients and therapeutic targets of HCP2001 have not been publicly disclosed as of the latest available data. The drug remains in early-stage development, with no reported approvals or advanced clinical phases[1][2][3].
- Brand names
- Sil-Dapa-Met
- Other names
- dapagliflozin + sitagliptin + metformindapagliflozin/sitagliptin/metformin FDC
02
Targets
DPP-4 (Dipeptidyl Peptidase-IV)AMPK (Adenosine monophosphate–activated protein kinase)SGLT2 (Sodium-glucose cotransporter protein subunit 2)ND1 (Mitochondrial electron transport chain complex I)
Beyond the preview
Go deeper on HCP2001.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HCP2001.